Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Alise Reicin | Chief Executive Officer | 2025-06-20 | 859 | $19.81 | $17.02kSell |
Timothy A. Springer | Director | 2025-04-11 | 53,706 | $16.31 | $875.94kBuy |
Timothy A. Springer | Director | 2025-04-11 | 9,478 | $16.31 | $154.59kBuy |
Timothy A. Springer | Director | 2025-04-10 | 8,092 | $16.73 | $135.38kBuy |
Timothy A. Springer | Director | 2025-04-10 | 45,858 | $16.73 | $767.20kBuy |
Timothy A. Springer | Director | 2025-04-09 | 16,215 | $14.62 | $237.06kBuy |
Timothy A. Springer | Director | 2025-04-09 | 4,856 | $15.23 | $73.96kBuy |
Timothy A. Springer | Director | 2025-04-09 | 857 | $15.23 | $13.05kBuy |
Timothy A. Springer | Director | 2025-04-09 | 2,861 | $14.62 | $41.83kBuy |
Timothy A. Springer | Director | 2025-04-07 | 87,500 | $17.10 | $1.50MBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Timothy A. Springer | 32.19% | 6,024,338 | $154.04M | Insider |
Bruce Booth | 29.75% | 5,567,289 | $142.36M | Insider |
Braden Michael Leonard | 26.21% | 4,905,068 | $125.42M | Insider |
Atlas Venture Fund X LP | 25.42% | 4,756,478 | $121.62M | Insider |
Clarus Lifesciences III LP | 23.75% | 4,443,487 | $113.62M | Insider |
Atlas Venture Associates X LP | 19.83% | 3,710,052 | $94.87M | Insider |
Scott Requadt | 15.83% | 2,962,325 | $75.75M | Insider |
Blackstone Holdings II LP | 15.83% | 2,962,325 | $75.75M | Insider |
Fmr LLC | 14.97% | 2,800,876 | $71.62M | Institution |
Deep Track Capital LP | 7.49% | 1,401,938 | $35.85M | Institution |